The real cost of theoretic risk avoidance: the need to challenge unsubstantiated concerns...

Radioactive iodine (131I) therapy for differentiated thyroid cancer in Japan: current issues with historical review and future perspective

T Higashi, T Kudo, S Kinuya - Annals of nuclear medicine, 2012 - Springer
Abstract Radioactive iodine (RAI, 131 I) has been used as a therapeutic agent for
differentiated thyroid cancer (DTC) with over 50 years of history. Recently, it is now attracting …
Save Cite Cited by 41 Related articles All 10 versions

Radiation safety of outpatient 177Lu-octreotate radiopeptide therapy of neuroendocrine tumors

PJ Calais, JH Turner - Annals of nuclear medicine, 2014 - Springer
Purpose To demonstrate the safety of outpatient 7.8 GBq 177 Lu-DOTA-tyr 3-octreotate
radiopeptide therapy of neuroendocrine tumors by measurement of radiation exposures of …
Save Cite Cited by 62 Related articles All 10 versions

Outpatient therapeutic nuclear oncology

JH Turner - Annals of nuclear medicine, 2012 - Springer
In the beginning, nuclear medicine was radionuclide therapy, which has evolved into
molecular tumour-targeted control of metastatic cancer. Safe, efficacious, clinical practice of …
Save Cite Cited by 31 Related articles All 13 versions

Thyroid Cancer: Radiation Safety Precautions in 131I Therapy Based on Actual Biokinetic Measurements

B Liu, W Peng, R Huang, R Tian, Y Zeng, A Kuang - Radiology, 2014 - pubs.rsna.org
Purpose To formulate radiation precautions for patients with thyroid cancer who are
undergoing thyroid hormone withdrawal–induced hypothyroidism and iodine 131 (131I) …
Save Cite Cited by 27 Related articles All 4 versions

Outpatient 131I-rituximab radioimmunotherapy for non-Hodgkin lymphoma: a study in safety

PJ Calais, JH Turner - Clinical Nuclear Medicine, 2012 - journals.lww.com
Purpose This study aimed to establish the safety of outpatient 131 I-rituximab
radioimmunotherapy by measuring the radiation exposure of hospital staff, carers, and …
Save Cite Cited by 17 Related articles All 4 versions
[PDF] jst.go.jp

RI 内用療法の将来展望と提言

東達也， 池渕秀治， 内山眞幸， 織内昇， 絹谷清剛… - 核医学, 2016 - jstage.jst.go.jp
我が国では急激な甲状腺癌の増加や RI 内用療法施設の実稼働ベッド数の減少などから, RI
内用療法施設への入院待ち待機時間が延長し地域格差が広がっており, その現状はがん対策推進 …
Save Cite Cited by 5 Related articles All 3 versions